- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Lifecare ASA: Lifecare advances CE mark preparation for its groundbreaking medical device | 2 | Oslo Børs | ||
| Di | Lifecare ASA: Invitation to presentation of Q2 2025 results 20 August at 10.45 CEST | 2 | Oslo Børs | ||
| 05.08. | Lifecare ASA Secures REK Ethics Approval For First-In-Human CGM Trial | 2 | RTTNews | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 05.08. | Lifecare ASA: Lifecare receives ethics approval to initiate first-in-human trial in Norway | 3 | Oslo Børs | ||
| 08.07. | Lifecare ASA: Lifecare achieves full radio frequency compliance for CGM implant clearing the way for CE mark of electronics | 1 | Oslo Børs | ||
| 01.07. | Lifecare ASA: Lifecare advances electromagnetic compatibility compliance testing for CGM implant | 1 | Oslo Børs | ||
| 25.06. | Lifecare ASA: Share capital increase registered | 2 | Oslo Børs | ||
| 13.06. | Lifecare ASA: Final results following expiry of the exercise period for the Warrants issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 13.06. | Lifecare ASA: Notification of trade - exercise of warrants | - | Oslo Børs | ||
| 13.06. | Lifecare ASA: Last day of the Exercise Period for the Warrants issued in connection with the Rights Issue | 1 | Oslo Børs | ||
| 06.06. | Lifecare ASA: Notification of trade - exercise of warrants | 1 | Oslo Børs | ||
| 06.06. | Lifecare ASA: Last day of trading in the Warrants issued in connection with the Rights Issue | 1 | Oslo Børs | ||
| 02.06. | Lifecare ASA: Exercise price for the Warrants issued in connection with the Right Issue | 3 | Oslo Børs | ||
| 02.06. | Lifecare ASA: Commencement of the Exercise Period for the Warrants issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 30.05. | Lifecare ASA: Lifecare announces second clinical trial site at Pfützner Science & Health Institute in Mainz, Germany | 1 | Oslo Børs | ||
| 27.05. | Lifecare ASA: Lifecare appoints renowned metabolic expert Prof. Simon Dankel as Principal Investigator for upcoming clinical trial | 2 | Oslo Børs | ||
| 20.05. | Lifecare ASA: Lifecare files for human clinical trial, paving the way for CE-mark | 4 | Oslo Børs | ||
| 16.05. | Lifecare ASA: Livestream strategic update | 7 | Oslo Børs | ||
| 09.05. | Lifecare ASA: Invitation to presentation of Q1 2025 results and strategic update | 9 | Oslo Børs | ||
| 24.04. | Lifecare ASA: Minutes from Annual General Meeting | 1 | Oslo Børs |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 77,36 | +0,23 % | Jefferies reiterates Hold rating on Roku stock, cites AI momentum | ||
| SERNOVA BIOTHERAPEUTICS | 0,118 | -2,48 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 88,00 | -0,23 % | Consumer alert: Recall notice issued for certain Boston Scientific Encore medical devices and kits | ||
| PAUL HARTMANN | 231,00 | -0,43 % | Januar bis Juni 2025: PAUL HARTMANN behauptet sich in herausforderndem Marktumfeld | Heidenheim (ots) - - Umsatzerlöse steigen auf 1.214,0 Mio. EUR, organisches Umsatzwachstum von 1,6 % - Bereinigtes EBITDA liegt bei 125,8 Mio. EUR, bereinigte EBITDA-Rendite bei 10,4 % - Transformationsprogramm... ► Artikel lesen | |
| SYSMEX | 11,800 | +0,85 % | Sysmex Q1 Profit Declines | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Sysmex reported first quarter profit attributable to owners of the parent of 4.55 billion yen, down 58.7% from last year. Earnings per share was 7.30 yen... ► Artikel lesen | |
| ADDLIFE | 14,730 | +0,07 % | AddLife AB: Interim Report January 1 - June 30, 2025 | Continued improvement in margins and profit"The companies within AddLife continue to develop in line with our priorities. Margins are strengthening in both business areas thanks to continuous development... ► Artikel lesen | |
| EMBECTA | 11,900 | +1,71 % | Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results | PARSIPPANY, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and nine... ► Artikel lesen | |
| ENOVIS | 26,000 | +2,36 % | Enovis raises 2025 revenue guidance to $2.275B amid CEO transition and product momentum | ||
| KANGJI MEDICAL | 0,930 | +1,64 % | XFRA 50J: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| PULMONX | 1,300 | -2,26 % | Pulmonx korrigiert Umsatzprognose nach unten - US-Geschäft schwächelt | ||
| SI-BONE | 13,500 | +1,50 % | SI-BONE stock price target reiterated at $25 by Cantor Fitzgerald | ||
| PEIJIA MEDICAL | 0,985 | +2,07 % | PEIJIA-B (09996): DATE OF BOARD MEETING | ||
| KOOTH | 1,800 | 0,00 % | Kooth PLC - Appointment of Joint Corporate Broker | ||
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle & Wellness Ltd: Revitalist Announces Filing of Audited Financial Statements for the Year-Ended December 31, 2022 and Provides Update on Cease Trade Order | Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) (the "Company") wishes to announce that, further to... ► Artikel lesen | |
| BACTIGUARD | 2,330 | -3,72 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2025 | Positive EBITDA momentum carried forward in Q2
Second quarter 2025 (April - June)
Total revenue amounted to SEK 52.1 (60.9) million, a decrease of SEK 8.8 million corresponding to 14.4%.
Net sales... ► Artikel lesen |
LIFECARE ASA gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 1,275 Euro und damit -18,01 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.